Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
March 19, 2024
Young Adult Virtual Event Series: “Times Are A-Changin’: Heading into Young Adulthood with a Desmoid Tumor.”
November 27, 2023
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
November 14, 2023
DTRF Leadership Team Attends CTOS 2023
November 3, 2023
DTRF Hosts the 2023 “Together We Will” Weekend in Philadelphia
Read More about DTRF Hosts the 2023 “Together We Will” Weekend in Philadelphia
October 30, 2023
Reflections From Jeanne Whiting, Our Retiring Executive Director And DTRF’s Co-Founder
October 1, 2023
Ten New ICD-10-CM Diagnosis Codes For Desmoid Tumors Go Into Effect on October 1, 2023, in the United States.
September 30, 2023
Desmoid Tumor Awareness Month 2023 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2023 Comes To A Close
September 26, 2023
DTRF Press Release: The Desmoid Tumor Research Foundation Announces That Groundbreaking Results From The Phase 3 Springworks Defi Trial Were Published Today In The New England Journal Of Medicine (More)
June 12, 2023
Coverage of Desmoid Tumors at ASCO 2023
May 21, 2023
Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
Read More about Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
May 9, 2023
NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
Read More about NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
